State-of-the-Art Clinical Symposium
About the Event
Date:April 4–6, 2025
Location:Chicago, IL
Credit:CME: 10.00, ABIM MOC: 10.00
On Demand:To Be Announced
Preview What's to Come at SOTA 2025
FIT@SOTA
The Fellows in Training (FIT) at SOTA program takes place on April 4. There is no other SOTA programming on that date. FITs interested in attending FIT@SOTA on April 4 and SOTA April 5-6, should select the FIT@SOTA pass when registering. See FIT@SOTA information.
Note: The FIT@SOTA activity is not CME or MOC-accredited.
During the State-of-the-Art Clinical Symposium (SOTA), key opinion leaders will deliver a range of content in areas such as therapeutic developments, recent research findings, and scientific advances, in an environment conducive to dialogue and networking.
Target Audience
Rheumatologists (physicians) in clinical care and/or research, fellows in training, division directors, program directors, assistant program directors, physician assistants, nurse practitioners, pharmacists, nurses, and epidemiologists.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize and differentiate the clinical presentations and phenotypes of patients with complex rheumatic diseases including relapsing polychondritis, IgG4-related disease, and hypermobility syndromes to enhance diagnostic accuracy and individualized patient care.
- Discuss the most up-to-date evidence-based treatment approaches including novel therapies, in the management of a variety of rheumatic diseases including relapsing polychondritis, osteoporosis, and spondyloarthritis.
- Discuss and implement current recommendations regarding pregnancy and reproductive health issues pertinent to women and men with rheumatic disease.
- Summarize and apply guidelines for cancer screening in myositis, with a focus on identifying specific subtypes that necessitate more intensive monitoring, to enhance early detection and improve patient outcomes in this vulnerable population.
See information from the 2024 meeting in the State-of-the-Art Clinical Symposium 2024 section below.
Program Schedule & Syllabi
State-of-the-Art Clinical Symposium 2025 Program Schedule
Registered attendees can access the syllabi during the meeting and until 11:59 PM ET on December 31, 2025. To access syllabi, login and go to My Learning.
Registration Fees
Registration for the State-of-the-Art Clinical Symposium 2025 is open.
Regular Rate: (begins January 17)
ACR Member and Fellow of the ACR: $673
ARP Member: $436
ACR and ARP Transitional Member: $336
ACR and ARP Student/Resident Member: $0
Developing Country: $0*
Food & Beverage Guest Pass (Non-CME): $200
*Members from Developing Countries: To be eligible for the reduced fee, members from countries with low-income and lower-middle-income economies, as determined by the World Bank, must provide evidence of work and residence address to education@rheumatology.org.
Regular Rate (begins January 17)
Potential Member: $1,011
Fellow in Training (ACR Transitional Potential Member): $506*
Developing Country: $0*
Food & Beverage Guest Pass (Non-CME): $200
*Potential Members from Developing Countries: To be eligible for the reduced fee, potential members from countries with low-income and lower-middle-income economies, as determined by the World Bank, must provide evidence of work and residence address to education@rheumatology.org.
Cancellations and Refund Requests
All registrations are final and non-refundable. Please submit any issues in writing to education@rheumatology.org and they will be evaluated on a case-by-case basis. If a refund is granted, an administrative fee will be deducted: $125.
- No-shows will not receive a refund.
- ACR is not responsible for airfare, hotel, or other costs incurred by participants in the event of a program or registration cancellation, or delays or cancellations due to inclement weather.
- Cancelled registrations are nontransferable.
Hotel
Hyatt Regency McCormick Place Chicago
2233 S Martin Luther King Dr
Chicago, IL 60616
312-567-1234
Book Hotel
Nightly Rates
$199
Room rates are subject to city/state taxes. The current tax rate is 17.3% (tax rate is subject to change).
After March 3 room rates cannot be guaranteed. Check with the hotel for any early departure fees and cancellation/refund policies. Rooms are on a first-come, first-serve basis.
Note: All programming will take place at the McCormick Place South Building. It is approximately a 5-minute walk from the Hyatt Regency McCormick Place to the convention center.
Travel
Airport Options
Midway Airport (MDW) – 9 miles to hotel
O'Hare International Airport (ORD) – 20 miles to hotel
Airport Ground Transportation
Midway Airport
MDW Ground Transportation Details
Taxis can be found at the lower-level inner lane in the section specified for taxis.
O'Hare International Airport
ORD Ground Transportation Details
Taxis can be found at the lower-level curb front (outside of Baggage Claim) at each terminal.
Loading zones for rideshare services are at Terminal 2, located on the Upper Level between Door 2A and Door 2E.
Ground transportation from the Chicago O’Hare Airport to the Hyatt Regency McCormick Place hotel is an approximate 45-minute ride.
- Taxi costs: $55–$75
- Uber costs: $55–$75
Prices are subject to change.
Rental cars can be acquired at designated areas in each airport.
Parking
There are both valet and self-parking options at the Hyatt Regency McCormick Place hotel.
See parking details and pricing
Press Registration
The American College of Rheumatology welcomes members of the press to write about research presented at our meetings. Complimentary registration is provided to approved members of the press to allow them to attend sessions on site.
Press registration for SOTA 2025 is closed. The deadline to apply was March 21.
Acknowledgement of Commercial Support
No commercial support was provided for this activity.
CME
ACCME Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.
AMA Designation Statement
The ACR designates this blended learning activity encompassing live and on demand activity for a maximum of 10.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by December 31, 2025 at 11:59 PM.
MOC
MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
MOC points must be claimed by December 31, 2025 at 11:59 PM.
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.
- SOTA 2025 Financial Relationships Disclosures (coming soon)
- SOTA 2025 Mitigation Spreadsheet (coming soon)
- View ACR's ACCME disclosure practices
See 2024 disclosures in the 2024 meeting section below.
During the State-of-the-Art Clinical Symposium (SOTA), key opinion leaders delivered a range of content in areas such as therapeutic developments, recent research findings, and scientific advances, in an environment conducive to dialogue and networking.
Target Audience
Rheumatologists (physicians) in clinical care and/or research, fellows in training, division directors, program directors, assistant program directors, physician assistants, nurse practitioners, pharmacists, nurses, and epidemiologists.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the most up-to-date evidence-based treatment approaches in the management of rheumatic diseases
- Identify and describe recent scientific and clinical advances regarding the pathogenesis of rheumatology
Program Schedule & Syllabi
State-of-the-Art Clinical Symposium 2024 Full Schedule
Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.
CME
ACCME Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.
AMA Designation Statement
The ACR designates this blended learning activity encompassing live and on demand activity for a maximum of 9.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by December 31, 2024.
MOC
MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
MOC points must be claimed by December 31, 2024.
Financial Relationships Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.
SOTA 2024 Financial Relationships Disclosures
View ACR's ACCME disclosure practices
Acknowledgement of Commercial Support
Unrestricted medical educational grant support for this activity has been provided by:
Janssen Scientific Affairs, LLC
Pfizer